SCHEMBL21859441

SCHEMBL21859441

CN1CCC(=C2c3ccc(Br)cc3CCc3sccc32)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.69
ADRA2A P08913 5/20 0.69
CHRM1 P11229 5/20 0.69
DRD1 P21728 5/20 0.69
DRD3 P35462 5/20 0.69
ADRA1A P35348 4/20 0.69
KCNH2 Q12809 4/20 0.69
ADRA2B P18089 4/20 0.69
HTR2A P28223 4/20 0.69
HTR2C P28335 4/20 0.69
HRH1 P35367 4/20 0.69
LMNA P02545 4/20 0.69
HTR3A P46098 3/20 0.69
ADRA2C P18825 3/20 0.69
ADRA1D P25100 3/20 0.69
HTR2B P41595 3/20 0.69
HTR1A P08908 3/20 0.69
SLC6A2 P23975 3/20 0.69
SLC6A4 P31645 3/20 0.69
SLC6A3 Q01959 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2615126 0.86 CHRM2 (0.69) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL21859237 0.85 HRH1 (0.67) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL13285186 0.85 CHRM2 (0.67) CHRM2ADRA2ACHRM1DRD1DRD3
Pizotyline SCHEMBL44122 0.82 DRD1 (1.00) CHRM2ADRA2ACHRM1DRD1DRD3
Pizotyline SCHEMBL29366884 0.82 DRD1 (1.00) CHRM2ADRA2ACHRM1DRD1DRD3
Pizotyline SCHEMBL8771138 0.82 DRD1 (1.00) CHRM2ADRA2ACHRM1DRD1DRD3
Pizotyline SCHEMBL11436430 0.81 DRD1 (0.97) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL3036650 0.74 MAPK1 (0.64) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL11521925 0.73 SETD7 (0.73) CHRM2ADRA2ACHRM1DRD1DRD3
SCHEMBL14007275 0.73 PTAFR (0.76) CHRM2CHRM1ADRA1AKCNH2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063999-A1 MONO HALOGEN OR METHYL-SUBSTITUTED 5-HT2B ANTAGONISTS WITH INCREASED ACTIVITY NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2020-04-02 WO disclosed